search

Master Hb Goals: The Winning Score for Haemodialysis Success!

This article is brought to you by Cresp  

Optimum Hb target in Haemodialysis patient
Optimum Hb target in Haemodialysis patient
Optimum Hb target in Haemodialysis patient
Optimum Hb target in Haemodialysis patient
Critical aspects of Hb levels in CKD patients on haemodialysis
Critical aspects of Hb levels in CKD patients on haemodialysis
Effect of treatment on Hb levels in haemodialysis patient
Effect of treatment on Hb levels in haemodialysis patient
Key factors affecting Hb variability
Key factors affecting Hb variability
Improving Hb management in haemodialysis
Improving Hb management in haemodialysis
Hb target in Haemodialysis
Hb target in Haemodialysis

Abbreviations ▼

ESA: Erythropoiesis-stimulating agent; Hb: Haemoglobin.

References ▼

1. Portolés JM, De Francisco ÁLM, Górriz JL, et al. Maintenance of target hemoglobin level in stable hemodialysis patients constitutes a theoretical task: a historical prospective study. Kidney International. 2008;74:S82–S87.2. Coyne DW, Goldsmith D, Macdougall IC. New options for the anemia of chronic kidney disease. Kidney International Supplements. 2017;7(3):157–163.3. Gembillo G, Siligato R, Santoro D. Personalized Medicine in Kidney Disease. JPM. 2023. 16;13(10):1501.

LMRC Code: GGI-CO-A1-AQS-300027678-BANNERS-G24-0738

 

Cresp 1

Cresp®(Biosimilar of darbepoetin alpha), a product by Dr. Reddy's is an erythropoiesis-stimulating agent which helps in treatment of renal anemia in pre-dialysis patients

Know more
Cresp

Related Articles

Latest Advancements for Hyperkalemia Therapeutics in Non-Dialysis Chronic Kidney Disease

Stay informed about the latest therapeutic options for managing hyperkalemia in non-dialysis CKD.

Updates on New Therapies for Patients with CKD

Explore the latest therapies, including ARNI and finerenone, proven to slow CKD progression and protect...

Keep Up to Date: Discover the KDIGO 2024 Guidelines for CKD Management!

Learn the latest KDIGO recommendations for evaluating CKD risk in adults and managing stages G3-G5

Escalating Economic Toll of Chronic Kidney Disease!

Learn how anemia in CKD significantly raises healthcare expenses—uncover the full economic impact.

KDIGO 2024 Recommendations for Lupus Nephritis Management

Discover the latest diagnostic and management recommendations for lupus nephritis from KDIGO 2024.

Building and Preserving Wealth - Key Challenges

From Stethoscope to Smartphone

NutriXpert: Nutrition intervention in Dialysis Patients: Recent evidence in Indian patients

A COVID update on 2- DG & Sputnik V in Diabetes

A COVID update on 2DG & Sputnik V in Diabetes

Efficacy, safety, and feasibility of roxadustat as part of a dialysis organization

The effect of ziltivekimab on hemoglobin levels in individuals with CKD stage 3-5

The impact of C-reactive protein on the efficacy of roxadustat in managing anemia in chronic kidney disease

Impact of high-dose intravenous iron on treatment outcomes and cardiovascular events in hemodialysis patients with renal anemia

Safety and efficacy of paclitaxel-coated balloons in treating dysfunctional arteriovenous fistulae

Urinary Tract Infections in Renal Insufficiency in CKD by Dr. R. K. Sahu

An Overview of Nephrotic Syndrome by Dr. Pranit Kakde

Anemia in CKD by Dr. V. B. Mohan

Management of Hypertension in CKD by Dr. Shashikanth

Conventional and Novel Therapies for Treating Iron-Deficiency Anemia in ND-CKD by Dr. Siddhesh Dhaygude